Clinical Trial Update: Lokomat Training Effects on MS Gait Abnormalities [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Lokomat robotic gait training for gait abnormalities in people with multiple sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: TERMINATED